Theragnostic Applications of Nanotechnologies
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 8
Special Issue Editors
Interests: hematological malignancies; nuclear medicine; PET; diagnostic imaging; imaging; medical imaging; medical imaging physics; computed tomography; clinical imaging; medical image analysis
Special Issues, Collections and Topics in MDPI journals
Interests: nuclear medicine; imaging; integrated imaging; high resolution scintigraphic detectors; heart failure; radionuclide therapy; dosimetry; target alpha therapy
Special Issues, Collections and Topics in MDPI journals
Interests: nuclear medicine; imaging; integrated imaging; high-resolution scintigraphic detectors; heart failure; radionuclide therapy; dosimetry; target alpha therapy
Special Issue Information
Dear Colleagues,
In recent years, we have witnessed and continue to witness the rapid evolution of imaging techniques which is providing an increasingly accurate diagnostic potential. Furthermore, personalized therapy is the most important goal of medicine of the future. Theragnostics, a branch of nuclear medicine that integrates the diagnostic phase with the therapeutic phase through the use of radiopharmaceuticals, undoubtedly represents one of the most promising frontiers in the healthcare sector. Nanotechnologies are configured as one of the frontiers of greatest interest and with greatest potential in the field of biomedical sciences. One of the most relevant aspects of nanotechnologies is represented by the need for the cooperation of professionalism, knowledge and skills from very disparate scientific fields: biomedicine, molecular biology, biochemistry, bio-inorganic chemistry, physics and engineering. In this context, nuclear medicine, in relation to its innate ability to interconnect with basic sciences and its most recent therapeutic applications, finds itself to be a natural interlocutor for those approaching nanotechnologies. The purpose of this Special Issue is precisely to explore and highlight the progress made in the various imaging and therapy techniques with the use of applied nanotechnologies, including, for example, the various nanoparticles of the most disparate materials, for use in digital radiography, molecular nuclear, CT, MRI and ultrasound, without therapeutic applications with radionuclides. The potential for integration between the different approaches and medical specialties, with the aim of creating links or direct connections with the patient, the main stakeholder of diagnostic imaging and personalized therapy, represents a principle of fundamental relevance in this scenario in which nanotechnologies are the protagonists.
Dr. Viviana Frantellizzi
Dr. Giuseppe De Vincentis
Dr. Maria Silvia De Feo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnologies
- theragnostics
- nuclear medicine
- personalized therapy
- CT
- MRI
- radionuclides
- nanoparticles
- PET
